ANDA 86494, held by Teva. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 86494 (Chlordiazepoxide Hydrochloride), held by Teva, was first approved by FDA on Feb 4, 1981, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 4, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride25MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
| Oct 7, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Feb 4, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters